LI, Chiang, J.,LI, Youzhi,BORODYANSKY, Laura,GAO, Yuan,LEGGETT, David,KERSTEIN, David, P.
申请号：
SG11201708505W
公开号：
SG11201708505WA
申请日:
2016.04.18
申请国别(地区):
SG
年份:
2017
代理人:
摘要：
Methods comprising administration of and kits comprising at least one compound of formula (I)； and at least one additional anti-cancer therapy chosen from panitumumab, cetuximab, capecitabine, CAPOX, regorafenib, and FOLFOX.
